3rd Annual BCAN Symposium

Jefferson Urology 3rd Annual Symposium 2020

Each year the Jefferson Urology Symposium focuses on a specific topic in Urology. This year our Symposium focused on Men’s Health and was held on February 1st, 2020. Our annual CME based Symposium combines the use of didactic lectures and hands on experience with simulated models with experts assisting in the learning process. In our 3rd Annual Jefferson Urology Symposium, nationally recognized experts in their subspecialties discussed topics of interest to men’s health. This conference may have been one of the last in person conference attended by many of the participants since it occurred just prior to the Covid-19 pandemic shutdown.

Topics covered included: • The Diagnosis and Management of Patients with Low Testosterone • The Use of Biomarkers in the Diagnosis and

Treatment of Prostate Cancer • Peyronie’s Disease – What Do We Know Now and How Do We Treat It? • The Medical and Surgical Treatment of

Erectile Dysfunction • BPH: An Update on Minimally Invasive

Therapy including Aquablation • Male Urinary Incontinence • HoLEP- Technique, Outcomes, and Current

Strategies • Strategies in Developing a Men’s Health

Center

Visiting faculty included Arthur L. Burnett, II, MD, MBA from Johns Hopkins University School of Medicine, Mohit Khera, MD, MBA, MPH from Baylor College of Medicine Houston, TX and Claus Roehrborn, MD Chair of Urology UT Southwestern Medical Center in Dallas, TX. Jefferson faculty included Course Director Akhil Das, MD, Paul Chung, MD, Leonard Gomella, MD and Perry Weiner, DO Director of Jefferson’s Men’s Health program at the Navy Yard. Proceedings of the Annual Symposium were published in a special supplement of the Canadian Journal of Urology International in August 2020.

The Department of Urology expresses our appreciation to our corporate sponsors and exhibitors who made the meeting possible: Boston Scientific, Endo Pharmaceuticals, KARL STORZ Endoscopy-America, Lumenis, Neotract Teleflex, Astellas Pharma US, Coloplast, Macklin Medical, Merck, Pfizer, Photocure, Procept BioRobotics, Retrophin and Uramix. This year our 4th Jefferson Urology Symposium will be held on April 30, 2021, and will focus on Management of Urinary Incontinence and Innovative Technologies for BPH. In coordination with the CME office at Jefferson, this course will be available via Zoom that includes expert panel discussions with question and answer sessions after each subsection of the didactic lectures. While we are disappointed that this symposium will not be in live in person, our collective experience of “virtual conferences” over the last year will allow us to provide a comprehensive review of these commonly treated urologic conditions to potentially a larger audience.

Dr. Ryan Mark and other members of the Sidney Kimmel Cancer Center discussed treatment and wellness strategies for patients fighting bladder cancer. The Virtual Symposium was in conjunction with the BCAN Walk to End Bladder Cancer held in Philadelphia on September 10, 2020.

Above: Faculty participants at Jefferson Urology 3rd Annual Symposium. From Left to right, Dr. Paul Chung, Dr. Arthur “Bud” Burnett, from Johns Hopkins, Dr. Akhil Das, Dr.

Leonard Gomella, Dr. Claus Rhoehrborn, Chair of Urology at UT Southwest in Dallas, Dr. Mohit Khera, from Baylor

College of Medicine in Houston and Dr. Perry Weiner.

Left: Proceedings of the 3rd Annual Urology Symposium were published in the Canadian Journal of Urology

International in August 2020. The entire supplement is available online at: www.canjurol.com/pdfs/ supplements/2020/CJUI_2020_THOMAS_

JEFFERSON_SUPPLEMENT.pdf

BCAN Bladder Cancer Symposium